These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31918401)

  • 1. Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone.
    Schneider KE; O'Rourke A; White RH; Park JN; Musci RJ; Kilkenny ME; Sherman SG; Allen ST
    Int J Drug Policy; 2020 Feb; 76():102642. PubMed ID: 31918401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Take-home naloxone possession among people who inject drugs in rural West Virginia.
    Allen ST; White RH; O'Rourke A; Grieb SM; Kilkenny ME; Sherman SG
    Drug Alcohol Depend; 2019 Nov; 204():107581. PubMed ID: 31574407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of recent nonfatal overdose among people who inject drugs in West Virginia.
    Ahmad NJ; Allen ST; White RH; Schneider KE; O'Rourke A; Perdue M; Babcock C; Kilkenny ME; Sherman SG
    Harm Reduct J; 2021 Feb; 18(1):22. PubMed ID: 33602226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship Between Polysubstance Injection Drug Use, HIV Risk Behaviors, and Interest in Pre-Exposure Prophylaxis (PrEP) Among People Who Inject Drugs in Rural West Virginia.
    Schneider KE; White RH; Musci RJ; O'Rourke A; Kilkenny ME; Sherman SG; Allen ST
    J Stud Alcohol Drugs; 2020 Nov; 81(6):740-749. PubMed ID: 33308403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: A latent class analysis.
    Schneider KE; Park JN; Allen ST; Weir BW; Sherman SG
    Drug Alcohol Depend; 2019 Aug; 201():71-77. PubMed ID: 31195347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico.
    Meacham MC; Roesch SC; Strathdee SA; Lindsay S; Gonzalez-Zuniga P; Gaines TL
    Drug Alcohol Rev; 2018 Jan; 37(1):128-136. PubMed ID: 28337798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia.
    O'Rourke A; White RH; Park JN; Rodriguez K; Kilkenny ME; Sherman SG; Allen ST
    Harm Reduct J; 2019 Aug; 16(1):51. PubMed ID: 31470864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
    Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
    Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative exploration of barriers and facilitators to drug treatment services among people who inject drugs in west Virginia.
    Winiker AK; Schneider KE; Hamilton White R; O'Rourke A; Grieb SM; Allen ST
    Harm Reduct J; 2023 Jun; 20(1):69. PubMed ID: 37264367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis.
    McAuley A; Bouttell J; Barnsdale L; Mackay D; Lewsey J; Hunter C; Robinson M
    Addiction; 2017 Feb; 112(2):301-308. PubMed ID: 27614084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia: Variations across capital cities.
    Dietze PM; Stare M; Cogger S; Nambiar D; Olsen A; Burns L; Lenton S
    Drug Alcohol Rev; 2018 May; 37(4):457-463. PubMed ID: 29744979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Take-Home Naloxone and risk management from the perspective of people who survived an opioid overdose in Stockholm - An analysis informed by drug, set and setting.
    Holmén E; Hammarberg A; Kåberg M; Storbjörk J
    Int J Drug Policy; 2023 May; 115():104021. PubMed ID: 37011507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fentanyl Preference among People Who Inject Drugs in West Virginia.
    Mazhnaya A; O'Rourke A; White RH; Park JN; Kilkenny ME; Sherman SG; Allen ST
    Subst Use Misuse; 2020; 55(11):1774-1780. PubMed ID: 32441202
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence and correlates of receptive syringe-sharing among people who inject drugs in rural Appalachia.
    White RH; O'Rourke A; Kilkenny ME; Schneider KE; Weir BW; Grieb SM; Sherman SG; Allen ST
    Addiction; 2021 Feb; 116(2):328-336. PubMed ID: 32533612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives.
    Lintzeris N; Monds LA; Bravo M; Read P; Harrod ME; Gilliver R; Wood W; Nielsen S; Dietze PM; Lenton S; Shanahan M; Jauncey M; Jefferies M; Hazelwood S; Dunlop AJ; Greenaway M; Haber P; Ezard N; Malcom A
    Drug Alcohol Rev; 2020 Jan; 39(1):55-65. PubMed ID: 31774221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
    O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
    Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection Drug Use Frequency Before and After Take-Home Naloxone Training.
    Colledge-Frisby S; Rathnayake K; Nielsen S; Stoove M; Maher L; Agius PA; Higgs P; Dietze P
    JAMA Netw Open; 2023 Aug; 6(8):e2327319. PubMed ID: 37540514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overdose Experiences among People Who Inject Drugs in West Virginia: Personal Loss, Psychological Distress, Naloxone, and Fentanyl.
    Schneider KE; Allen ST; Winiker AK; White RH; O'Rourke A; Sherman SG; Grieb SM
    Subst Use Misuse; 2023; 58(1):22-26. PubMed ID: 36371695
    [No Abstract]   [Full Text] [Related]  

  • 19. Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.
    Holmén E; Warnqvist A; Kåberg M
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):24. PubMed ID: 37087485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid Overdose Outbreak - West Virginia, August 2016.
    Massey J; Kilkenny M; Batdorf S; Sanders SK; Ellison D; Halpin J; Gladden RM; Bixler D; Haddy L; Gupta R
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):975-980. PubMed ID: 28934186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.